Publikationen, an denen er mitarbeitet Joan Genescà Ferrer (14)

2023

  1. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

    Gut, Vol. 72, Núm. 4, pp. 749-758

  2. Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis

    Hepatology (Baltimore, Md.), Vol. 77, Núm. 6, pp. 2052-2062

2022

  1. Baveno VII – Renewing consensus in portal hypertension

    Journal of Hepatology, Vol. 76, Núm. 4, pp. 959-974

  2. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

    Journal of Hepatology, Vol. 76, Núm. 4, pp. 812-821

2021

  1. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data

    Gastroenterology, Vol. 160, Núm. 1, pp. 193-205.e10

  2. Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis

    JHEP Reports, Vol. 3, Núm. 6

2020

  1. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF

    Journal of Hepatology, Vol. 72, Núm. 4, pp. 688-701

  2. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

    Journal of Hepatology, Vol. 73, Núm. 5, pp. 1082-1091

2018

  1. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis

    Gastroenterology, Vol. 154, Núm. 6, pp. 1694-1705.e4

2016

  1. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension

    Hepatology, Vol. 63, Núm. 1, pp. 197-206

2015

  1. Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study

    Hepatology, Vol. 62, Núm. 2, pp. 575-583

2013

  1. Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study

    Hepatology, Vol. 58, Núm. 6, pp. 2079-2088

2012

  1. Portal hypertension: Recommendations for evaluation and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd)

    Gastroenterologia y Hepatologia, Vol. 35, Núm. 6, pp. 421-450

2003

  1. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: A double-blind RCT

    Hepatology, Vol. 37, Núm. 6, pp. 1260-1266